Qube Research & Technologies (QRT)
ONCT

Qube Research & Technologies (QRT)’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– -$1 – 5023
2023
Q4 		– Hold
0
– – – 4290
2023
Q3 		– Hold
0
– – – 4393
2022
Q4 		– Sell
-1,908
Closed -$34K – 3136
2022
Q3 		$34K Sell
1,908
-107
-5% -$2.29K ﹤0.01% 2216
2022
Q2 		$45K Buy
+2,015
New +$44.9K ﹤0.01% 2145
2021
Q3 		– Sell
-3,713
Closed -$353K – 2925
2021
Q2 		$353K Buy
+3,713
New +$441K ﹤0.01% 1478

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $324M AUM 37.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ONCT Position: Q1 2024 in Review

Qube Research & Technologies (QRT) held its Oncternal Therapeutics, Inc. Common Stock (ONCT) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5023.

Qube Research & Technologies (QRT) first reported a position in ONCT in Q2 2021 and has held it in 3 quarters since. The position peaked at $353K in Q2 2021. 24 funds tracked by Wall St. Rank hold ONCT as of Q1 2024.

  • Qube Research & Technologies (QRT) held 0 shares of Oncternal Therapeutics, Inc. Common Stock worth $0 as of Q1 2024.
  • Qube Research & Technologies (QRT) left its Oncternal Therapeutics, Inc. Common Stock share count unchanged in Q1 2024.
  • Oncternal Therapeutics, Inc. Common Stock made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2024, its #5023 holding.
  • Qube Research & Technologies (QRT) first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2021 and has held it in 3 quarters since.
  • Qube Research & Technologies (QRT)'s Oncternal Therapeutics, Inc. Common Stock position peaked at $353K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.